How Long Vyvanse Stays in Your System
Vyvanse (lisdexamfetamine) is detectable in your body for approximately 2-3 days after a single dose, with the active metabolite dextroamphetamine having an elimination half-life of 10-11 hours in adults and being largely cleared within 48-72 hours.
Pharmacokinetic Timeline
The detection window depends on which component you're measuring and which biological matrix is tested:
Blood/Plasma Detection
- Lisdexamfetamine (parent drug): Becomes non-quantifiable by 8 hours after administration, with a half-life of less than 1 hour 1
- Dextroamphetamine (active metabolite): Half-life of 10-11.3 hours in adults and 8.6-9.5 hours in children 1
- Blood concentrations are most useful for detecting use within 2-12 hours 2
Urine Detection
- Detection window: 67-78 hours (approximately 3 days) after a single therapeutic dose 3
- Using standard screening cutoffs (50 ng/mL for amphetamine), detection can extend up to 5 days with higher doses 4
- Approximately 96% of the dose is recovered in urine over 120 hours, with 42% as amphetamine, 25% as hippuric acid, and only 2% as intact lisdexamfetamine 1, 5
Oral Fluid (Saliva) Detection
- Detection window: 67-69 hours (approximately 3 days) after a single therapeutic dose, comparable to urine 3
- Oral fluid detects recent use within 24-48 hours most reliably 2
- Requires very sensitive analytical methods (cutoff as low as 1.5 ng/mL for amphetamine) 3
Key Factors Affecting Detection Time
Dose-dependent: Higher doses extend detection windows. The data above reflect single therapeutic doses (30-70 mg). Chronic use or higher doses will prolong detection 4, 6.
pH-dependent elimination: This is a critical caveat. Urinary pH significantly affects amphetamine excretion:
- Acidic urine (pH <6): Increases excretion, shortens detection time
- Alkaline urine (pH >7): Decreases excretion, prolongs detection time 1
Individual variability: Despite low inter-subject variability in pharmacokinetics (<25%), detection times show substantial individual variation, likely due to differences in urinary pH and metabolic rates 1, 3.
Clinical Context
The prodrug design of lisdexamfetamine means it must be enzymatically converted to dextroamphetamine by red blood cells before becoming active 1, 5. This conversion process:
- Creates a delayed peak effect (Tmax of 3.5-4.4 hours for dextroamphetamine vs. 1 hour for lisdexamfetamine) 1
- Results in minimal systemic exposure to the parent drug (20-fold lower than dextroamphetamine) 5
- Makes alternative routes of administration (intranasal) pharmacokinetically similar to oral, limiting abuse potential 7
Practical Detection Windows Summary
For standard drug testing purposes:
- Blood: Up to 24 hours reliably
- Urine: 2-3 days (single dose), up to 5 days (higher doses)
- Oral fluid: 2-3 days (requires sensitive methods)
- Hair: Not useful for recent use; cannot detect use within previous 7-10 days 2
Important caveat: These timeframes assume therapeutic dosing. Chronic use, higher doses, or alkaline urine can extend detection windows significantly 4, 6.